Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ponatinib hydrochloride

EU orphan designation number: EU/3/14/1421   
Active ingredient: Ponatinib hydrochloride
Indication: Treatment of gastrointestinal stromal tumours
Sponsor: Incyte Biosciences UK Ltd
Riverbridge House, Guildford Road, Leatherhead, Surrey KT22 9AD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2015 Orphan designation EMA/OD/212/14 (2015)185 of 15/01/2015
22/11/2016 Transfer of orphan designation EMA/OD/212/14/T/01 (2016)7587 of 18/11/2016